Table 1.
Demographic data of 233 patients with non-massive hemoptysis
| Characteristic | Value (N = 233) |
|---|---|
| Age (years) | 56.9 ± 14.8 |
| Sex (male/female) | 143/90 |
| Underlying disease | |
| DM/HTN | 17/34 |
| Causes of non-massive hemoptysis | |
| TB sequelae | 99 (42.5) |
| Bronchiectasis | 31 (13.2) |
| Tuberculosis destroyed lung | 25 (10.9) |
| Aspergilloma | 26 (11.1) |
| Fibrotic scar change | 17 (7.3) |
| Active TB | 31 (13.2) |
| Mycobacterium tuberculosis | 28 (11.9) |
| Multidrug-resistant tuberculosis | 3 (1.3) |
| Nontuberculous mycobacteria | 8 (3.3) |
| Bronchiectasis without TB | 35 (15.2) |
| Pneumonia | 27 (11.6) |
| Lung cancer | 11 (4.6) |
| Others | 22 (9.6) |
| Amount of hemoptysis (mL) | |
| < 50 | 92 (39.5) |
| 50–100 | 81 (34.7) |
| 101–200 | 57 (24.5) |
| 201–300 | 3 (1.3) |
| Pre-procedural evaluationa | |
| Contrast-enhanced CT + Bronchoscopy | 147 (63.1%) |
| Contrast-enhanced CT | 72 (31.0%) |
| Bronchoscopy | 3 (1.2%) |
| None | 11 (4.7%) |
| In-hospital mortality | |
| Yesb | 5 (2.1) |
| No | 228 (97.9) |
Values in parentheses represent percentages. aContrast-enhanced chest CT and bronchoscopy were performed within 3 months before BAE. bFive patients died following complications of underlying diseases (heart failure, 3 patients; multiorgan failure, 2 patients). CT, computed tomography, DM, diabetes mellitus, HTN, hypertension, TB, tuberculosis